Pharmacological characterization of the cardiovascular responses elicited by kinin B1 and B2 receptor agonists in the spinal cord of streptozotocin-diabetic rats-Reference-Cited by-同舟云学术

Pharmacological characterization of the cardiovascular responses elicited by kinin B1 and B2 receptor agonists in the spinal cord of streptozotocin-diabetic rats

Published:2000-05 Issue:2 Volume:130 Page:375-385
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Cloutier Frank,Couture Réjean

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/sj.bjp.0703319/fullpdf

Reference52 articles.

1. Novel subtype-selective nonpeptide bradykinin receptor antagonists FR167344 and FR173657;ARAMORI;Mol. Pharmacol.,1997

2. Structure and genomic organization of the human B1 receptor gene for kinins (BDKRB1);BACHVAROV;Genomics,1996

3. Neurogenic cutaneous vasodilatation and plasma extravasation in diabetic rats: effect of insulin and nerve growth factor;BENNETT;Br. J. Pharmacol.,1998

4. Molecular mechanisms of diabetic angiopathy-clues for innovative therapeutic interventions;BIERHAUS;Horm Res.,1998

5. In vivo B1 kinin-receptor upregulation. Evidence for involvement of protein kinases and nuclear factor κB pathways;CAMPOS;Br. J. Pharmacol.,1999

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemical, biological and protein-receptor binding profiling of Bauhinia scandens L. stems provide new insights into the management of pain, inflammation, pyrexia and thrombosis;Biomedicine & Pharmacotherapy;2021-11

2. Kinin receptors: Key regulators of autoimmunity;Autoimmunity Reviews;2017-02

3. Inflammatory muscle pain is dependent on the activation of kinin B1 and B2 receptors and intracellular kinase pathways;British Journal of Pharmacology;2012-05-08

4. Characterization of upper thoracic spinal neurons receiving noxious cardiac and/or somatic inputs in diabetic rats;Autonomic Neuroscience;2011-12

5. The therapeutic potential of bradykinin B1 inhibitors in chronic pain;Drugs of the Future;2011